Hemangkumar Javaiya

Hemangkumar Javaiya practices at Valuecare Clinic in Jacksonville, Florida.

Hemangkumar Javaiya's NPI, 1952604464, was assigned on December 6, 2010. Hemangkumar Javaiya holds Florida license ME154659.

Hemangkumar Javaiya's primary practice is Valuecare Clinic, at 2732 Trollie Ln, Jacksonville, FL 32211-3833. The practice phone is (904) 289-1254. The NPI Registry lists Hemangkumar Javaiya's practice address as 4201 Belfort Rd, Jacksonville, FL 32216.

Hemangkumar Javaiya's primary practice is Valuecare Clinic in Jacksonville, Florida. Hemangkumar Javaiya is also affiliated with Ascension St. Vincent's Southside Hospital. The medical group on file is HNI Healthcare. Dmand AI also links Hemangkumar Javaiya to 4 more medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Hemangkumar Javaiya practices, 2 sites in all. Vendor and product names are available with a free account.

Internal medicine is Hemangkumar Javaiya's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dmand AI has Hemangkumar Javaiya's licenses on file in 2 states: Florida and New Jersey.

CMS data shows 304 Medicare services from Hemangkumar Javaiya across 4 procedure codes in 2024, for 79 Medicare patients. Medicare paid $23,039 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 79 Medicare patients who saw Hemangkumar Javaiya in 2024. The largest group is 75 to 84, with 33 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 18% are also on Medicaid. Their average risk score is 2.95, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Hemangkumar Javaiya's median patient age at 68, with 33% women.

In 2024, Hemangkumar Javaiya wrote 70 Medicare Part D claims for 18 patients. 71% of them were for generic drugs. CMS names the drug for 14 of them, across 1 drug with 11 or more claims each, at $8,489 in total drug cost. In 2022, CMS named 84 claims across 6 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 99 out of 100 for Hemangkumar Javaiya for performance year 2024, reported as part of a group.

Dmand AI links 4 papers to Hemangkumar Javaiya, published from 2011 to 2017. Hemangkumar Javaiya's most frequent co-authors are Avani Changela, MD, Kinesh Arvindkumar Changela, MD and Fahad Syed Naseerullah, MD.

CMS Open Payments shows 1 general payment to Hemangkumar Javaiya from 1 drug or device company in 2017. Food and beverage make up the largest share, 100% of the total. Aralez Pharmaceuticals US Inc. paid the most, $71.